Fred E. Cohen - 26 Jul 2023 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
26 Jul 2023
Net transactions value
+$661,494
Form type
4
Filing time
28 Jul 2023, 18:06:09 UTC
Previous filing
21 Jun 2023
Next filing
08 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Award $661,494 +69,339 $9.54 69,339 26 Jul 2023 by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the reporting person's proportionate interest in shares acquired by entities affiliated with Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer